• Schneider Electric in its $900 million divestiture of Telvent DTN, a leader in providing information services, supply chain connectivity tools and decision support solutions to the agricultural, energy and environmental industries, to TBG AG, a private Swiss holding company.
    • Allergan in its $2.47 billion acquisition of ZELTIQ, a medical technology company focused on utilizing its proprietary CoolSculpting controlled-cooling technology platform, the sales leader in the fast-growing body contouring segment of medical aesthetics.
    • Johnson & Johnson in its purchase of an exclusive option to acquire Bird Rock Bio, a clinical stage biopharmaceutical company focused on innovative immuno-inflammatory regulators that can be used in the treatment of liver disease.
    • New York Life Investments in its acquisition of a majority interest in Credit Value Partners, a distressed and high-yield debt investment management business.
    • Allergan in its $2.9 billion acquisition of LifeCell Corporation, a regenerative medicine business.
    • Tribune Media Company in the $560 million sale of Gracenote, a leading entertainment data provider, to the Nielsen Company.
    • Morgan Stanley Private Equity in its acquisition of Cadence Education, a leading provider of early childhood education.
    • Providence Service Corporation in a strategic partnership with Frazier Healthcare Partners in Matrix Medical Network.
    • Envision Healthcare in its $15 billion merger with AMSURG, creating one of the largest U.S. providers of specialty physicians and hospital-related services.
    • American Securities and P2 Capital Partners in their $855 million acquisition of Blount International.
    • Kelso & Company in its acquisition of the J.M. Smucker Company‚Äôs U.S. canned milk brands and operations.
    • Morgan Stanley Private Equity in its acquisition of CoAdvantage, a leading Professional Employer Organization.
    • J.C. Flowers and Ascensus in the sale of Ascensus to Genstar Capital and Aquiline Capital Partners.
    • Kelso & Company in its acquisition of Sirius Computer Solutions, a leading national IT solutions integrator.
    • J. P. Morgan as financial advisor to Salix Pharmaceuticals in its $15.8 billion sale to Valeant Pharmaceuticals.


  • Columbia Law School, 2014, J.D.
  • New York University, 2007, M.B.A.
  • Ohio State University, 1999, B.A.